A Bioactive Trypanosoma cruzi Bromodomain Inhibitor from Chemically Engineered Extracts
I. Ayelen Ramallo, Victoria L. Alonso, Federico Rua, Esteban Serra, Ricardo L. E. Furlan
Index: 10.1021/acscombsci.7b00172
Full Text: HTML
Abstract
A set of chemically engineered extracts enriched in compounds including N–N and N–O fragments in their structures was prepared. Bromodomain binding screening and bioguided fractionation led to the identification of one oxime hit that interacts with TcBDF3 with affinity in the submicromolar range and that shows interesting antiparasitic properties against the different life cycle stages of T. cruzi.
Latest Articles:
A Parallel Approach to 7-(Hetero)arylpyrazolo[1,5-a]pyrimidin-5-ones
2018-04-06
[10.1021/acscombsci.8b00032]
Solid-Phase Synthesis of β-Hydroxy Ketones Via DNA-Compatible Organocatalytic Aldol Reactions
2018-04-03
[10.1021/acscombsci.8b00001]
2018-03-26
[10.1021/acscombsci.8b00004]
Development and Application of a Sensitive Peptide Reporter to Discover 20S Proteasome Stimulators
2018-03-23
[10.1021/acscombsci.7b00193]
2018-03-23
[10.1021/acscombsci.8b00007]